Want to join the conversation?
$DF said that Ralph Scozzafava, EVP and COO, will succeed Gregg Tanner as the company's CEO and as a member of the company's BoD, effective Jan. 1, 2017. To carry out a smooth transition, Gregg Tanner will remain as an adviser to the company through the Annual Stockholders Meeting in May 2017.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.